Global Mitochondrial Myopathy Diagnosis & Treatment Market Professional Survey Report 2019
The global Mitochondrial Myopathy Diagnosis & Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growin...
$3,500.00 15 October, 2019 | QYResearch
Global Mitochondrial Myopathy Diagnosis & Treatment Market Professional Survey Report 2019
$3,500.00 | 15 October, 2019 | QYResearch
The global Mitochondrial Myopathy Diagnosis & Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 20...
Scope of the Report: The worldwide market for Anaplastic Lymphoma Kinase Inhibitors is expected to grow at a CAGR of roughly xx% over the next five years, wi...
$3,480.00 15 October, 2019 | GIR (Global Info Research)
Global Anaplastic Lymphoma Kinase Inhibitors Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
$3,480.00 | 15 October, 2019 | GIR (Global Info Research)
Scope of the Report: The worldwide market for Anaplastic Lymphoma Kinase Inhibitors is expected to grow at a CAGR of roughly xx% over the next five...
Frontier Pharma - Small Cell Lung Cancer: Diverse First-in-Class Pipeline Shows Promise of Targeted Therapies to Treat Aggressive Disease Summary Initially...
$6,995.00 24 October, 2019 | GlobalData
Frontier Pharma - Small Cell Lung Cancer: Diverse First-in-Class Pipeline Shows Promise of Targeted Therapies to Treat Aggressive Disease
$6,995.00 | 24 October, 2019 | GlobalData
Frontier Pharma - Small Cell Lung Cancer: Diverse First-in-Class Pipeline Shows Promise of Targeted Therapies to Treat Aggressive Disease Summary ...
Deal-Making Trends in Pharma - Thematic Research
Deal-Making Trends in Pharma - Thematic Research Summary To gain a better understanding of the pharmaceutical deal landscape, this report will dive into th...
$1,950.00 24 October, 2019 | GlobalData
Deal-Making Trends in Pharma - Thematic Research
$1,950.00 | 24 October, 2019 | GlobalData
Deal-Making Trends in Pharma - Thematic Research Summary To gain a better understanding of the pharmaceutical deal landscape, this report will di...
The analysts forecast the global healthcare wipe market to exhibit a CAGR of 5.6% during the period 2019-2024. The report covers the present scenario and the...
$3,000.00 25 October, 2019 | Gen Consulting Company
The analysts forecast the global healthcare wipe market to exhibit a CAGR of 5.6% during the period 2019-2024. The report covers the present scenar...
Global IV and Oral Iron Drugs Market Size, Status and Forecast 2019-2025
This report focuses on the global IV and Oral Iron Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to...
$3,900.00 29 October, 2019 | QYResearch
Global IV and Oral Iron Drugs Market Size, Status and Forecast 2019-2025
$3,900.00 | 29 October, 2019 | QYResearch
This report focuses on the global IV and Oral Iron Drugs status, future forecast, growth opportunity, key market and key players. The study objecti...
Allergic Rhinitis Immunotherapy: Opportunity Analysis and Forecasts to 2028
Allergic Rhinitis Immunotherapy: Opportunity Analysis and Forecasts to 2028 Summary Allergic rhinitis (AR) is a common, IgE-mediated inflammatory disease i...
$10,995.00 31 October, 2019 | GlobalData
Allergic Rhinitis Immunotherapy: Opportunity Analysis and Forecasts to 2028
$10,995.00 | 31 October, 2019 | GlobalData
Allergic Rhinitis Immunotherapy: Opportunity Analysis and Forecasts to 2028 Summary Allergic rhinitis (AR) is a common, IgE-mediated inflammatory...
Myasthenia Gravis: Epidemiology Forecast to 2028
Myasthenia Gravis: Epidemiology Forecast to 2028 Summary Myasthenia gravis (MG) is the most common neuromuscular junction disorder, and is characterized by...
$3,995.00 31 October, 2019 | GlobalData
Myasthenia Gravis: Epidemiology Forecast to 2028
$3,995.00 | 31 October, 2019 | GlobalData
Myasthenia Gravis: Epidemiology Forecast to 2028 Summary Myasthenia gravis (MG) is the most common neuromuscular junction disorder, and is charac...
Ovarian Cancer: Opportunity Analysis and Forecasts to 2028
Ovarian Cancer: Opportunity Analysis and Forecasts to 2028 Summary Ovarian cancer is a rare gynecological disease that spans a broad range of genetic and h...
$10,995.00 31 October, 2019 | GlobalData
Ovarian Cancer: Opportunity Analysis and Forecasts to 2028
$10,995.00 | 31 October, 2019 | GlobalData
Ovarian Cancer: Opportunity Analysis and Forecasts to 2028 Summary Ovarian cancer is a rare gynecological disease that spans a broad range of gen...
Female Infertility: Opportunity Analysis and Forecasts to 2028
Female Infertility: Opportunity Analysis and Forecasts to 2028 Summary Female infertility (FI) is a complex disorder defined as the inability to conceive a...
$10,995.00 31 October, 2019 | GlobalData
Female Infertility: Opportunity Analysis and Forecasts to 2028
$10,995.00 | 31 October, 2019 | GlobalData
Female Infertility: Opportunity Analysis and Forecasts to 2028 Summary Female infertility (FI) is a complex disorder defined as the inability to ...